Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001213900-25-051435·Cellyan Biotechnology Co., Ltd
Schedule 13G ownership disclosure
CELLYAN BIOTECHNOLOGY CO LTD
Ordinary Shares, $0.001 par value · CUSIP: G6365B104
Event date: 2025-03-31
- Filing-level shares
- 617,850.00
- Percent of class
- 5.62%
- Pacific Health Century International Group
Shares: 617,850.00 · Class: 5.62%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-051435
- Form type
- SCHEDULE 13G
- Filer
- Cellyan Biotechnology Co., Ltd
- CIK
- CIK 2007702
- Filed
- Jun 05, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership